Cargando…

Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?

Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?

Detalles Bibliográficos
Autores principales:	Valmori, Danila, Ayyoub, Maha
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2004
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529422/ https://www.ncbi.nlm.nih.gov/pubmed/15578104 http://dx.doi.org/10.1371/journal.pmed.0010026

Ejemplares similares

Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity
por: Saito, Kanako, et al.
Publicado: (2015)

We Don’t Have to Lose STEM Students to Business
por: Wernick, Naomi L. B., et al.
Publicado: (2020)

Farewell to the Lose–Lose Reality of Policing Plant Imports
por: Zamir, Dani
Publicado: (2016)

Universal Health Coverage: Are We Losing Our Way on Women’s and Children’s Health?
por: Bustreo, Flavia, et al.
Publicado: (2019)

Am I losing it?
por: Mann, Norman M.
Publicado: (2012)

Don’t lose samples to estimation
por: Tsamardinos, Ioannis
Publicado: (2022)

Are we losing the war on cancer?
por: El-Deiry, Wafik S
Publicado: (2013)

Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients
por: Saito, Kanako, et al.
Publicado: (2016)

Dredging in the Spratly Islands: Gaining Land but Losing Reefs
por: Mora, Camilo, et al.
Publicado: (2016)

Chimeric antigen receptor modified T-cells for cancer treatment
por: Han, Xiao, et al.
Publicado: (2018)

Tuberculosis in times of COVID-19: we cannot lose focus on the diagnosis
por: Torres, Pedro Paulo Teixeira e Silva, et al.
Publicado: (2022)

Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients
por: Sardaro, Alessandro, et al.
Publicado: (2016)

A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens
por: Sutherland, Colin
Publicado: (2007)

MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now?
por: Labate, Angelo, et al.
Publicado: (2023)

Multiple sclerosis: why we should focus on both sides of the (auto) antibody
por: den Dunnen, Jeroen, et al.
Publicado: (2021)

Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
por: Stojko, Michał, et al.
Publicado: (2023)

Canjiqueira Fruit: Are We Losing the Best of It?
por: Arakaki, Daniela G., et al.
Publicado: (2020)

Infodemics - Are We Losing Knowledge in Information?
por: Sogi, Girish Malleshappa
Publicado: (2022)

Exclosure (or what we risk losing)
por: Hecht, Marijke
Publicado: (2023)

NY-ESO-1-Specific Circulating CD4(+) T Cells in Ovarian Cancer Patients Are Prevalently T(H)1 Type Cells Undetectable in the CD25(+)FOXP3(+)Treg Compartment
por: Redjimi, Nassima, et al.
Publicado: (2011)

Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
por: Lokhov, Petr G., et al.
Publicado: (2022)

Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link
por: Dolecek, Christiane, et al.
Publicado: (2022)

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need
por: Jin, Pengfei, et al.
Publicado: (2021)

COVID-19 Vaccine Acceptance: We Need to Start Now
por: Kuppalli, Krutika, et al.
Publicado: (2021)

COVID‐19 vaccines and their underbelly: Are we going the right way?
por: Satapathy, Bhabani Sankar, et al.
Publicado: (2023)

Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy
por: Hamaï, Ahmed, et al.
Publicado: (2011)

Toward a genome sequence for every animal: Where are we now?
por: Hotaling, Scott, et al.
Publicado: (2021)

We should abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis
por: Hurley, Sadhbh, et al.
Publicado: (2022)

Chromatin Remodeling in Development and Disease: Focus on CHD7
por: Martin, Donna M.
Publicado: (2010)

Ethics in Science: Are We Losing the Moral High Ground?
por: Sanai, Faisal M.
Publicado: (2008)

Not Until We Lose Our Sanity or Anymore Lives
por: Abu Dabrh, Abd Moain
Publicado: (2019)

Junying Yuan: Changing avenues without losing focus
por: LeBrasseur, Nicole
Publicado: (2007)

Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project
por: Okuma, Hitomi S., et al.
Publicado: (2019)

Sorting Reality from What We Think We Know About Breast Cancer in Africa
por: Mohammed, Sulma I., et al.
Publicado: (2014)

Availability and use of Standards in vaccine development
por: Avumegah, Michael Selorm, et al.
Publicado: (2023)

COVID-19–We urgently need to start developing an exit strategy
por: Petersen, Eskild, et al.
Publicado: (2020)

Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models
por: Tomioka, Ikuo, et al.
Publicado: (2018)

If we designed airplanes like we design drugs…
por: Woltosz, Walter S.
Publicado: (2011)

We know what we want, it’s just not there
por: Freundlich, Robert E., et al.
Publicado: (2021)

SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?
por: Heldman, Madeleine R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vbenm6gdkftbr5q238dg159b3r